MILFORD, Mass. — SeraCare Life Sciences, a leading partner to global in vitro diagnostics manufacturers and clinical diagnostics laboratories announces two important development milestones to their growing portfolio of next-generation sequencing (NGS)-based tools for Precision Medicine. Early access programs for the first commercial, novel circulating tumor DNA (ctDNA) reference materials and multiplex RNA fusion reference […]
BOULDER, CO – ArcherDX, Inc., the leader in NGS-based gene fusion detection, has announced an agreement with GenomOncology, Inc., the leader in NGS variant interpretation, to co-market Archer’s NGS assays and GenomOncology’s data interpretation software for somatic mutation detection and reporting. Under terms of the agreement, GenomOncology’s GO Clinical Workbench™ will now support interpretation of […]
SAN ANTONIO; SHANGHAI; CAMBRIDGE, Mass.; REYKJAVIK; and MADRID, November 3, 2015 – The San Antonio 1000 Cancer Genomes Project (SA1kCGP), WuXi NextCODE, and South Texas Accelerated Research Therapeutics (START) today announced a partnership that will enable San Antonio’s pioneering city-wide cancer genomics effort to contribute directly to improving the clinical treatment of cancer around the […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) announced that A. Barry Rand has retired from its board of directors, effective Oct. 31. Rand, 70, was a founding director of Agilent, having served on the board of directors since the company’s spinoff from Hewlett-Packard Co. in 2000. Rand is a highly respected business leader, […]
Redwood City, California, and Hilden, Germany – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced enhancements to its QIAGEN Clinical Insight® (QCI™) clinical decision support solution, which streamlines the annotation, interpretation and reporting of next-generation sequencing results (NGS) for clinical laboratories. The QCI bioinformatics platform, launched earlier this year, has been expanded from […]
SAN DIEGO – Illumina (Nasdaq:ILMN) today announced that its Board of Directors has authorized the company to repurchase, on a discretionary basis, up to $250 million of its outstanding common shares in the open market or in privately negotiated transactions, subject to market conditions and other factors. The company also announced the completion of the […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced that the Australian Genome Research Facility Ltd—a nonprofit organization dedicated to enabling world-class genomics research throughout Australia—is now an Agilent Certified Service Provider for next-generation sequencing. Agilent certifies select laboratories that leverage the company’s market-leading technologies to provide analysis services of the highest quality. […]
Ann Arbor, MI – Rubicon Genomics, Inc., today announced an agreement with Eurofins Genomics for U.S. distribution of its DNA library preparation products, including the ThruPLEX® DNA-seq kit and Rubicon’s new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for cell-free DNA to enable the preparation of NGS libraries for liquid biopsies–the analysis of cell-free […]
ST. LOUIS, Mo. and PALO ALTO, Calif. – PierianDx, makers of the leading bioinformatics platform for clinical genomics testing, and Syapse, the leading provider of precision medicine software, announced a partnership that will accelerate the adoption of precision medicine by healthcare systems. The companies will provide functional integration between PierianDx’s Clinical Genomicist WorkstationTM and Syapse […]
Cambridge, UK : Horizon Discovery Group plc (LSE:HZD) (Horizon), the international life science company supplying research tools and services to organizations engaged in genomics research and the development of personalized medicines, today announced it has entered into a new agreement with Swift Biosciences (Swift). Swift will be incorporating Horizon’s human genomic reference standards into its […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
